Angela Mastronuzzi

<p><strong>Prof. Angela Mastronuzzi</strong> is Head of the Neuro-Oncology Unit within the Department of Hematology-Oncology, Cell Therapy, Gene Therapies and Hematopoietic Transplantation at Bambino Ges&ugrave; Children&rsquo;s Hospital in Rome. She is Associate Professor of General and Specialized Pediatrics at Universit&agrave; Cattolica del Sacro Cuore and teaches in several Master&rsquo;s and PhD programs at Sapienza University of Rome. She is also President of AIEOP, the Italian Association of Pediatric Hematology-Oncology. Her clinical activity focuses on pediatric central nervous system tumors and cancer predisposition syndromes, with extensive expertise in innovative therapies, including phase I trials, targeted therapy, cell therapy and gene therapy.&nbsp;Prof. Mastronuzzi has led or contributed to over 50 phase I/II/III clinical trials and protocols. Her research focuses on precision medicine and artificial intelligence in pediatric cancer, within major EU-funded projects.&nbsp;<br><strong>Dr. Andrea Carai</strong>, PhD, MD, is Chief of the Neurosurgery Unit at Bambino Ges&ugrave; Children&rsquo;s Hospital in Rome, actively collaborating with the Neuro-Oncology Unit. He studied medicine at the University of Sassari; later completed his neurosurgery residency at the same university in 2007 and his PhD fellowship in biomedical sciences with a focus on the nervous system in 2011. He served as a research fellow in 2009 and as visiting professor in 2012 at the Neurosurgery Department of the Mount Sinai Hospital in New York City. In 2018 he received a master&rsquo;s degree in Pediatric Neurology and in 2020 a master&rsquo;s degree in Management and Direction of Healthcare Companies. Dr. Carai's main interests include innovative intraoperative visualization solutions (fluorescence assisted surgery, intraoperative imaging, image guided surgery), integration of virtual reality and simulation in the clinical practice and reduction of neurosurgical morbidity for the improvement of quality of life of children from the neurosurgical perspective. He is passionate about innovation and his work in clinical research. He is a Board Member and Chair of the Special Interest Group Neurosurgery of the Posterior Fossa Society (SNO) and member of the SIOP-E Brain Tumor Working Group -Neurosurgery.</p>